Online inquiry

IVTScrip™ mRNA-Human AP1S2, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK18577MR)

This product GTTS-WK18577MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 1 & N1-Methylpseudo-UTP. It ecodes the AP1S2 protein. This product can be used in Meiotic prophase fetal germ cell-related researches.
Specifications
Product type mRNA
Modified bases N1-Methylpseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_001272071.2
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 8905
UniProt ID P56377
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human AP1S2, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) (GTTS-WK18577MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK23717MR IVTScrip™ mRNA-Human APOA4, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA APOA4
GTTS-WK28782MR IVTScrip™ mRNA-Human ATP1A1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ATP1A1
GTTS-WK8129MR IVTScrip™ mRNA-Human ABCA13, (Cap 0, 2-Thio-UTP, 120 nt-poly(A)) mRNA ABCA13
GTTS-WK24529MR IVTScrip™ mRNA-Human ASTN2, (Cap 0, 2-Thio-UTP, 30 nt-poly(A)) mRNA ASTN2
GTTS-WK19476MR IVTScrip™ mRNA-Human AP1M1, (Cap 1, 5-Methyl-CTP, 120 nt-poly(A)) mRNA AP1M1
GTTS-WK20575MR IVTScrip™ mRNA-Human Androgen-binding protein, (Cap 1, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA Androgen-binding protein
GTTS-WK10827MR IVTScrip™ mRNA-Human ABCA1, (Cap 1, Pseudo-UTP, 120 nt-poly(A)) mRNA ABCA1
GTTS-WK18475MR IVTScrip™ mRNA-Human Androgen-binding protein, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA Androgen-binding protein
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW